CN Patent

CN106279047B — 一种前列环素受体激动剂的制备方法

Assigned to Puji Biotechnology (Taizhou) Co., Ltd. · Expires 2019-05-03 · 7y expired

What this patent protects

本发明涉及前列环素受体激动剂2‑{4‑[N‑(5，6‑二苯基吡嗪‑2‑基)‑N‑异丙基氨基]丁氧基}‑N‑(甲基磺酰基)乙酰胺的制备方法，还涉及其中间体的制备方法。所述制备方法操作简便，产物收率良好、纯度高，环境友好，适合工业化生产。

USPTO Abstract

本发明涉及前列环素受体激动剂2‑{4‑[N‑(5，6‑二苯基吡嗪‑2‑基)‑N‑异丙基氨基]丁氧基}‑N‑(甲基磺酰基)乙酰胺的制备方法，还涉及其中间体的制备方法。所述制备方法操作简便，产物收率良好、纯度高，环境友好，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN106279047B
Jurisdiction
CN
Classification
—
Expires
2019-05-03
Drug substance claim
No
Drug product claim
No
Assignee
Puji Biotechnology (Taizhou) Co., Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.